IPAD-DB ID | D01177 |
Name | Acrylamide |
Category | Drugs |
2D Structure |
|
3D Structure | |
Molecular Formula | C 3 H 5 N O |
Molecular Weight | 71.08 |
IUPAC Name | prop-2-enamide |
InChI | InChI=1S/C3H5NO/c1-2-3(4)5/h2H,1H2,(H2,4,5) |
InChIKey | HRPVXLWXLXDGHG-UHFFFAOYSA-N |
Canonical SMILES | C=CC(=O)N |
PubChem CID | 6579 |
DrugBank Accession Number | - |
CAS Registry Number | - |
Molecular Weight(Computed by SwissADME) | 71.08 |
Hac(Computed by SwissADME) | 5 |
Volume(Computed by ADMETlab 2.0) | 74.958 |
Density(Computed by ADMETlab 2.0) | 0.948 |
nRing(Computed by ADMETlab 2.0) | 0 |
MaxRing(Computed by ADMETlab 2.0) | 0 |
nHet(Computed by ADMETlab 2.0) | 2 |
fChar(Computed by ADMETlab 2.0) | 0 |
nRig(Computed by ADMETlab 2.0) | 2 |
Flexibility(Computed by ADMETlab 2.0) | 0.5 |
Stero Centers(Computed by ADMETlab 2.0) | 0 |
LogS(Computed by ADMETlab 2.0) | 0.855 |
LogD(Computed by ADMETlab 2.0) | -0.898 |
logP(Computed by ADMETlab 2.0) | -0.515 |
TPSA(Computed by SwissADME) | 43.09 |
Hbond Acceptor(Computed by SwissADME) | 1 |
Hbond Donor(Computed by SwissADME) | 1 |
Rotatable Bonds(Computed by SwissADME) | 1 |
GI Absorption(Computed by SwissADME) | High |
BBB(blood-brain barrier) Permeant(Computed by SwissADME) | No |
P-gp Substrate(Computed by SwissADME) | No |
CYP1A2 Inhibitor(Computed by SwissADME) | No |
CYP2C19 Inhibitor(Computed by SwissADME) | No |
CYP2C9 Inhibitor(Computed by SwissADME) | No |
CYP2D6 Inhibitor(Computed by SwissADME) | No |
CYP3A4 Inhibitor(Computed by SwissADME) | No |
log Kp(Skin Permeation)(Computed by SwissADME) | -7.21 |
Lipinski(Computed by SwissADME) | 0 |
Ghose(Computed by SwissADME) | 3 |
Veber(Computed by SwissADME) | 0 |
Egan(Computed by SwissADME) | 0 |
Muegge(Computed by SwissADME) | 2 |
Bioavailability Score(Computed by SwissADME) | 0.55 |